Botond Igyártó

Has grant

Associate Professor

Thomas Jefferson University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

DC-subset-tailored vaccines

Open Date: 2020-06-17

Close Date: 2025-05-31

Grant: Close

Development of Universal Influenza Virus Vaccines Using Nucleoside-Modified Messenger RNA

Open Date: 2019-08-01

Close Date: 2024-07-01

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Matthew L. Bettini

University of Utah

UNITED STATES

View details

Toshiro Hirai

Specially appointed associate professor

Osaka University

JAPAN

View details

Casey Weaver

Professor

The University of Alabama

UNITED STATES

View details

Daniel H. Kaplan

University of Pittsburgh

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Botond Igyártó

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Local IL-23 is required for proliferation and retention of skin-resident memory T H 17 cells

Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion

“Don’t Look Up” Your Science—Herd Immunity or Herd Mentality?

Antibody-Mediated Targeting of a Hybrid-Insulin-Peptide Towards Neonatal Thymic Langerin+ Cells Enhances T Cell Central Tolerance and Delays Autoimmune Diabetes

Single-cell suspension preparation from murine organs following <i>in vivo</i> mRNA-LNP exposure.

Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 immune responses.

Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines.

The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory.

Anti-CD40 Antibodies Fused to CD40 Ligand Have Superagonist Properties.

Targeting human langerin promotes HIV-1 specific humoral immune responses.

Collaborators (4)

Matthew L. Bettini

Toshiro Hirai

Casey Weaver

Daniel H. Kaplan

Make your next move.